oliver sartor discusses clinical use of radium-223
Published 8 years ago • 31 plays • Length 0:42Download video MP4
Download video MP3
Similar videos
-
1:05
oliver sartor discusses common questions about radium-223
-
1:08
dr. a. oliver sartor on the mechanism of action of radium-223
-
1:04
dr. oliver sartor discusses radium-223 in early prostate cancer
-
2:25
sartor: expanded access program for radium-223 (xofigo)
-
1:25
dr. sartor discusses the novel agent radium-223
-
1:24
dr. sartor on mechanism of action and safety of radium-223 in mcrpc
-
1:41
dr. oliver sartor on doubling the dosage of radium-223 in patients with crpc
-
0:47
dr. oliver sartor discusses a new prostate cancer trial combining radium-223 and provenge
-
11:09
mri rectal cancer-tumor staging and imaging techniques
-
53:09
the oncoalert tumor boards prostate cancer june 20, 2022
-
44:23
beyond single-cell resolution: high-plex 3d profiling of tissues and tumors l prof. peter sorger
-
0:53
dr. sartor on impact of radium-223 for community oncologists
-
3:52
incorporating radium 223 in community practice
-
0:55
dr. sartor on patients in the alsympca radium-223 trial
-
25:26
radium-223 combinations: choosing a companion drug - oliver sartor
-
1:08
dr. sartor on provenge in combination with radium-223
-
1:38
dr. sartor on outcomes with 177lu-psma-617 after radium-223 in mcrpc
-
3:56
bone-targeted therapy for prostate cancer: radium-223
-
5:34
era 223 and implications for clinical practice
-
1:07
dr. szmulewitz on optimal use of radium-223 in mcrpc
-
0:46
dr. morris on mechanism of action for radium-223
-
15:05
radium-223 in bone-metastatic castration-resistant prostate cancer